| 包装 | 价格(元) |
| 500μg | 电议 |
| 1mg | 电议 |
| Canonical SMILES | O=C(N[C@@H](C(C)C)C(N[C@H](C(N[C@@H](CC1=CNC2=C1C=CC=C2)C(N)=O)=O)CSSC[C@H](NC([C@H](N)CC3=CC=CC=C3)=O)C4=O)=O)[C@H](CCCCN)NC([C@@H](CC5=CNC6=C5C=CC=C6)NC([C@@](CC7=CC=C(O)C=C7)([H])N4)=O)=O.FC(F)(C(O)=O)F |
| 分子式 | C57H70N12O9S2•XCF3COOH |
| 分子量 | 1131.4 |
| 溶解度 | Water: 1 mg/ml |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Vapreotide is a peptide neurokinin-1 receptor (NK1) antagonist and analog of somatostatin (IC50 = 330 nM in a radioligand binding assay). It inhibits increases in vascular permeability stimulated by substance P in a concentration-dependent manner in isolated guinea pig trachea and main bronchi. Vapreotide (8 nmol per animal) reduces substance P-induced biting and scratching in mice. It increases reaction time to heat stimuli in the hot plate and tail flick tests when administered at a dose of 512 μg/kg, indicating antinociceptive activity in mice. Vapreotide reduces plasma growth hormone (GH) increases induced by phenobarbital , morphine , and chlorpromazine , hypoglycemia-induced glucagon elevation, and glucose-induced insulin secretion in rats. It also decreases tumor weight and volume in a hamster model of pancreatic ductal adenocarcinoma and suppresses tumor growth and reduces GH secretion in SK-ES-1 and MNNG/HOS osteosarcoma mouse xenograft models. |
m.cnreagent.com